| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/12/2013 | US8394793 Therapeutic agent for inflammatory bowel disease |
| 03/12/2013 | US8394792 Heterocyclic derivatives |
| 03/12/2013 | US8394790 Psychotropic agents having glutamate NMDA activity |
| 03/12/2013 | US8394789 (Dihydro)pyrrolo[2,1-α]isoquinolines |
| 03/12/2013 | US8394788 Phenylsulfoxyoxazole compound inhibitors of urea transporters |
| 03/12/2013 | US8394787 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof |
| 03/12/2013 | US8394786 Quinazoline derivatives |
| 03/12/2013 | US8394785 Methods for the treatment and amelioration of urticaria |
| 03/12/2013 | US8394783 Polysaccharide gel formulation having multi-stage bioactive agent delivery |
| 03/12/2013 | US8394782 Polysaccharide gel formulation having increased longevity |
| 03/12/2013 | US8394781 Disaccharides for the treatment of tendons, ligaments, and bones |
| 03/12/2013 | US8394780 Targeting PAX2 for the treatment of breast cancer |
| 03/12/2013 | US8394778 Regulators of NFAT and/or store-operated calcium entry |
| 03/12/2013 | US8394776 Use of ursolic acid saponin,oleanolic acid saponin in preparation of increasing leucocytes and/or platelet medicine |
| 03/12/2013 | US8394774 Pesticidal compositions |
| 03/12/2013 | US8394773 Use of an alkyl glycoside or of a mixture of alkyl glycosides having anti-ageing and/or calming properties as active agents in cosmetic compositions, and methods of cosmetic care using said compositions |
| 03/12/2013 | US8394772 Glycoside derivative and uses thereof |
| 03/12/2013 | US8394757 Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists |
| 03/12/2013 | US8394629 Use of vinca alkaloids and salts thereof |
| 03/12/2013 | US8394628 RNA sequence-specific mediators of RNA interference |
| 03/12/2013 | US8394422 Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans |
| 03/12/2013 | US8394415 Modified release analgesic suspensions |
| 03/12/2013 | US8394414 Synthetic biodegradable microparticles incorporating a therapeutic, prophylactic or diagnostic agent having a diameter of 0.5-10 microns and release the agent at a pH of 6.0 or greater |
| 03/12/2013 | US8394407 Delayed release tablet with defined core geometry |
| 03/12/2013 | US8394406 Once daily formulations of tetracyclines |
| 03/12/2013 | US8394405 Once daily formulations of tetracyclines |
| 03/12/2013 | US8394402 Compositions and methods for the sustained release of beta-alanine |
| 03/12/2013 | US8394401 Antiobesity or antihyperlipidemic food, feeding stuff or supplement containing lysine |
| 03/12/2013 | US8394398 Apparatus for controlled delivery of drug agents for treatment and/or inhibition of neointimal hyperplasia in blood vessel lumen |
| 03/12/2013 | US8394397 Adhesive antineoplastic compositions |
| 03/12/2013 | US8394395 Use of a cosmetic composition for the care of fatty skin |
| 03/12/2013 | US8394393 System and method for the release of nitric oxide using nanoscale media |
| 03/12/2013 | US8394372 Stabilized protease composition |
| 03/12/2013 | US8394366 Thermosensitive polymers for therapeutic use and methods of preparation |
| 03/12/2013 | US8394365 Multi-arm polymer prodrugs |
| 03/12/2013 | US8394364 Methods of using ophthalmic compositions comprising povidone-iodine |
| 03/12/2013 | US8394361 Stable surfactant compositions for suspending components |
| 03/12/2013 | US8393321 Drug delivery system for conscious sedation |
| 03/12/2013 | CA2731773C Amidophenoxyindazoles useful as inhibitors of c-met |
| 03/12/2013 | CA2706661C Intermediates for the preparation of lipoxin a4 analogs |
| 03/12/2013 | CA2699568C Azaindoles |
| 03/12/2013 | CA2697551C Piperidine derivatives as modulators of gpr119 activity |
| 03/12/2013 | CA2695088C Novel piperazine amide derivatives |
| 03/12/2013 | CA2668210C Anilinopiperazine derivatives and methods of use thereof |
| 03/12/2013 | CA2649286C 2-hydroxybenzoic acid derivatives for treating or preventing degenerative and inflammatory diseases |
| 03/12/2013 | CA2640534C 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 03/12/2013 | CA2638573C Substituted 7-azabicyclo[2.2.1]heptyl derivatives useful for making pharmaceutical compositions |
| 03/12/2013 | CA2637933C Indole sulfonamide modulators of progesterone receptors |
| 03/12/2013 | CA2623507C Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration |
| 03/12/2013 | CA2619779C Use of a pde5 inhibitor for treating and preventing hypopigmentary disorders |
| 03/12/2013 | CA2612413C Compounds for inhibition of 5-hydroxytryptamine and norepinephrine reuptake or for treatment of depression disorders, their preparation processes and uses thereof |
| 03/12/2013 | CA2603826C Substituted oxazole derivatives and their use as tyrosine kinase inhibitors |
| 03/12/2013 | CA2590405C Piperidinesulfonylureas and -thioureas, their preparation, their use and pharmaceutical compositions comprising them |
| 03/12/2013 | CA2587335C Compositions, systems and methods for treatment of defects in blood vessels |
| 03/12/2013 | CA2571063C Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
| 03/12/2013 | CA2569763C 2,4-diaminoquinazolines for spinal muscular atrophy |
| 03/12/2013 | CA2567397C Use of neboglamine (cr 2249) as an antipsychotic and neuroprotective |
| 03/12/2013 | CA2566917C Compounds containing a n-heteroaryl moiety linked to fused ring moieties for the inhibition of nad(p)h oxidases and platelet activation |
| 03/12/2013 | CA2553266C Substituted quinolines and their use as mycobacterial inhibitors |
| 03/12/2013 | CA2551227C Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 03/12/2013 | CA2550350C 2-(hetero)aryl-substituted tetrahydroquinoline derivatives |
| 03/12/2013 | CA2545589C Phosphinic acid derivatives |
| 03/12/2013 | CA2543870C Therapeutic use of methionine for the treatment or prevention of mucositis |
| 03/12/2013 | CA2542332C Immunomodulating compositions and uses therefor |
| 03/12/2013 | CA2538904C Glutamine for use in treating injury |
| 03/12/2013 | CA2537936C Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists |
| 03/12/2013 | CA2533150C A doxycycline metal complex in a solid dosage form |
| 03/12/2013 | CA2531661C Histone deacetylase inhibitors and methods of use thereof |
| 03/12/2013 | CA2530381C Combination product comprising an antagonist or inverse agonist of histamine receptor h<sb>3 </sb>and an antipsychotic or antidepressant agent, and use thereof for the preparationof a medicament that prevents the adverse effects of psychotropic drugs |
| 03/12/2013 | CA2517077C Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 03/12/2013 | CA2510455C Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 03/12/2013 | CA2503383C Extended, controlled release pharmaceutical compositions comprising charged polymers |
| 03/12/2013 | CA2500310C Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics |
| 03/12/2013 | CA2473927C Methods and compositions for treating polycystic ovary syndrome |
| 03/12/2013 | CA2469685C Bispecific antisense oligonucleotides that inhibit igfbp-2 and igfbp-5 and methods of using same |
| 03/12/2013 | CA2464111C Phosphonic acid compounds as inhibitors of serine proteases |
| 03/12/2013 | CA2464092C Electroprocessing in drug delivery and cell encapsulation |
| 03/12/2013 | CA2437266C Taste-masked resinate and preparation thereof |
| 03/12/2013 | CA2437044C Method of determining a chemotherapeutic regimen based on ercc1 expression |
| 03/12/2013 | CA2405307C Application of substances acting as cascade inhibitors of the raf/mek/erk signaling cascade for the production of a drug against infections by dna and rna viruses |
| 03/12/2013 | CA2388505C 5-membered heterocycle derivatives, their preparation and application as medicine |
| 03/12/2013 | CA2373639C Adhesive n,o-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins |
| 03/12/2013 | CA2366865C Flupirtine in the treatment of fibromyalgia and related conditions |
| 03/12/2013 | CA2366787C Compositions and methods for treating lymphoma |
| 03/12/2013 | CA2353645C Novel methods of protecting plants from pathogens |
| 03/12/2013 | CA2285923C Methods and compositions for treating inflammatory bowel disease |
| 03/07/2013 | WO2013033688A1 Treatment of cancer |
| 03/07/2013 | WO2013033662A1 Limited release lingual thioctic acid delivery systems |
| 03/07/2013 | WO2013033642A1 Formulations and dosage forms of oxidized phospholipids |
| 03/07/2013 | WO2013033626A2 Nkp30 receptor targeted therapeutics |
| 03/07/2013 | WO2013033620A1 Compounds and compositions as pdgfr kinase inhibitors |
| 03/07/2013 | WO2013033602A2 Fatty acid amides, compositions and methods of use |
| 03/07/2013 | WO2013033569A1 Heterocyclylamines as pi3k inhibitors |
| 03/07/2013 | WO2013033520A1 A method for regulating skin pigmentation |
| 03/07/2013 | WO2013033476A1 Branched discrette peg constructs |
| 03/07/2013 | WO2013033461A1 Heterocyclic boronic acid ester derivatives and therapeutic uses thereof |
| 03/07/2013 | WO2013033432A1 Methods and compositions for treating type 2 diabetes and related conditions |
| 03/07/2013 | WO2013033430A1 Targeted delivery and prodrug designs for platinum-acridine anti-cancer compounds and methods thereof |
| 03/07/2013 | WO2013033420A1 Methods of downregulating translocated oncogene expression using bromodomain inhibitors |
| 03/07/2013 | WO2013033407A2 Identification of small molecules that enhance therapeutic exon skipping |